...
首页> 外文期刊>American Journal of Cancer Research >Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4
【24h】

Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4

机译:长的非编码RNA lncBRM通过上调Sox4促进卵巢癌细胞的增殖,迁移和侵袭

获取原文

摘要

Ovarian cancer (OC) is one of the most fatal gynecological cancer in women worldwide. Long noncoding RNA (lncRNA) lncBRM was found to be associated with the progression and prognosis of hepatocellular carcinoma (HCC). However, the expression level, clinical significance and functions in OC tumorigenesis and progression remain unclear. Our present research demonstrated that lncBRM expression was significantly increased in OC tissues. Upregulation of lncBRM expression was correlated with histological grade, FIGO stages, lymph node metastasis and poor prognosis of patients with OC. Functional assays showed that lncBRM positively regulated cell proliferation, migration and invasion in OC. Moreover, lncBRM upregulated Sox4 by competitively binding miR-204. Together, lncBRM functions as an oncogene in OC and can be a promising therapeutic target for OC treatment.
机译:卵巢癌(OC)是全球女性中最致命的妇科癌症之一。发现长非编码RNA(lncRNA)lncBRM与肝细胞癌(HCC)的进展和预后有关。然而,在OC肿瘤发生和发展中的表达水平,临床意义和功能尚不清楚。我们当前的研究表明,lncBRM表达在OC组织中显着增加。 lncBRM表达的上调与OC患者的组织学分级,FIGO分期,淋巴结转移和预后不良有关。功能测定表明,lncBRM在OC中正调控细胞的增殖,迁移和侵袭。此外,lncBRM通过竞争性结合miR-204上调Sox4。总之,lncBRM在OC中起癌基因的作用,并且可能成为OC治疗的有希望的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号